Michael J Pontecorvo

Summary

Publications

  1. pmc PET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's disease
    Michael J Pontecorvo
    Avid Radiopharmaceuticals, 3711 Market Street, 7th Floor, Philadelphia, PA 19104, USA
    Alzheimers Res Ther 3:11. 2011
  2. doi request reprint Use of florbetapir-PET for imaging beta-amyloid pathology
    Christopher M Clark
    Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, USA
    JAMA 305:275-83. 2011
  3. doi request reprint Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent
    John Lister-James
    Avid Radiopharmaceuticals, Philadelphia, PA
    Semin Nucl Med 41:300-4. 2011

Collaborators

  • Franz Hefti
  • Christopher M Clark
  • Mark A Mintun
  • Daniel M Skovronsky
  • Hank F Kung
  • John Lister-James
  • Alan P Carpenter
  • Seok Rye Choi
  • Eric P Reiman
  • Tyler E Benedum
  • Nathaniel Lim
  • P Murali Doraiswamy
  • Matthew L Flitter
  • Adam S Fleisher
  • Simone P Zehntner
  • Carl H Sadowsky
  • R Edward Coleman
  • Wei Zhang
  • Michael J Krautkramer
  • Warren B Bilker
  • Zhiping Zhuang
  • P Eric M Reiman
  • Chris Clark
  • Abhinay D Joshi
  • Thomas G Beach
  • Geoff Golding
  • Paul Kennedy
  • Barry J Bedell
  • Julie A Schneider
  • Marwan N Sabbagh

Detail Information

Publications3

  1. pmc PET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's disease
    Michael J Pontecorvo
    Avid Radiopharmaceuticals, 3711 Market Street, 7th Floor, Philadelphia, PA 19104, USA
    Alzheimers Res Ther 3:11. 2011
    ..Although large longitudinal studies like the ongoing ADNI trial will be required for definitive evaluation, present data suggest that PET amyloid imaging has the potential to promote earlier and more specific diagnosis of dementia...
  2. doi request reprint Use of florbetapir-PET for imaging beta-amyloid pathology
    Christopher M Clark
    Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, USA
    JAMA 305:275-83. 2011
    ..The ability to identify and quantify brain β-amyloid could increase the accuracy of a clinical diagnosis of Alzheimer disease...
  3. doi request reprint Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent
    John Lister-James
    Avid Radiopharmaceuticals, Philadelphia, PA
    Semin Nucl Med 41:300-4. 2011
    ..Clinical studies have demonstrated a clear correlation between in vivo PET imaging with florbetapir F-18 and postmortem histopathologic quantitation of β-amyloid in the brain...